| Analyst: | Veljee, Tahira | EPS
Est. Accuracy: | Not Avl.
| | Broker: | Virtua Research | Recommendation
Performance: | Not Avl.
|
|
| Stocks Covered
| |
Alkermes Inc (ALKS), Alnylam Pharmaceuticals Inc (ALNY), Biomarin Pharmaceutical Inc (BMRN), Cytrx Corp (CYTR), Cytori Therapeutics Inc (CYTX), Emergent Biosolutions Inc (EBS), Enzon Pharmaceuticals Inc (ENZN), Hemispherx Biopharma, Inc. (HEB), Immunomedics Incorporated (IMMU), Isis Pharmaceuticals Inc (ISIS), Kensey Nash Corporation (KNSY), Molecular Insight Pharma Inc (MIPI), Momenta Pharmaceuticals Inc (MNTA), Osi Pharmaceuticals Inc (OSIP), Poniard Pharmaceuticals Inc (PARD), Peregrine Pharmaceutical (PPHM), Regeneron Pharmaceuticals (REGN), Resmed Inc (RMD), Seattle Genetics Inc (SGEN), Stemcells Inc (STEM), Theravance Inc (THRX), Vertex Pharmaceuticals Inc (VRTX)
|
| | |
|
